WHO ICTRP trial
Effect of radiotherapy time in breast cancer
IRCT20180919041070N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20180919041070N1 |
|---|---|
| Public title | Effect of radiotherapy time in breast cancer |
| Scientific title | Comparison of the effectiveness of neoadjuvant with adjuvant radiotherapy in patients with early breast cancer |
| Primary sponsor | Iran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | breast cancer. Malignant neoplasm of breast |
| Interventions | Intervention 1: Intervention group: A group that received neoadjuvant radiation therapy (50 Gy in 25 fraction) and boost dose during surgery (12 Gy IORT)? then receive surgery, chemotherapy, and hormone therapy. Intervention 2: Intervention… |
| Registration date | Apr 4, 2019 |
| Target size | 120 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: